AIMS: Depression is a highly prevalent disorder in the elderly and one of the risk factors for developing dementia. The present study involves patients with Alzheimer's disease (AD), geriatric major depressive disorder (MDD) and cognitively healthy controls aiming to compare baseline cerebrospinal fluid (CSF) biomarkers. METHODS: The study included 52 patients with more than 60 years of age with a diagnosis of MDD, AD, and healthy controls. All individuals underwent a medical history, physical, and neurologic examination, laboratory tests and neuropsychological assessment to rule out any clinical diseases or disorders. Measurement of CSF P-tau(181) , T-tau, and Aβ42 was performed using commercial assays (ELISA). RESULTS: CSF Aβ42 levels of depressed patients and normal controls were significantly higher than in AD. There was not any significant difference in measures of P-tau among the groups. T-tau, however, showed to be significantly different among the groups, with higher measures in AD group. Higher levels of P-tau were observed in four MDD patients compared with controls. CONCLUSION: CSF Aβ42, T-tau, and P-tau levels may differentiate between AD and depression in a Brazilian sample.
AIMS: Depression is a highly prevalent disorder in the elderly and one of the risk factors for developing dementia. The present study involves patients with Alzheimer's disease (AD), geriatric major depressive disorder (MDD) and cognitively healthy controls aiming to compare baseline cerebrospinal fluid (CSF) biomarkers. METHODS: The study included 52 patients with more than 60 years of age with a diagnosis of MDD, AD, and healthy controls. All individuals underwent a medical history, physical, and neurologic examination, laboratory tests and neuropsychological assessment to rule out any clinical diseases or disorders. Measurement of CSF P-tau(181) , T-tau, and Aβ42 was performed using commercial assays (ELISA). RESULTS: CSF Aβ42 levels of depressedpatients and normal controls were significantly higher than in AD. There was not any significant difference in measures of P-tau among the groups. T-tau, however, showed to be significantly different among the groups, with higher measures in AD group. Higher levels of P-tau were observed in four MDDpatients compared with controls. CONCLUSION: CSF Aβ42, T-tau, and P-tau levels may differentiate between AD and depression in a Brazilian sample.
Authors: Breno S Diniz; Antonio L Teixeira; Rodrigo Machado-Vieira; Leda L Talib; Marcia Radanovic; Wagner F Gattaz; Orestes V Forlenza Journal: J Gerontol B Psychol Sci Soc Sci Date: 2014-08-22 Impact factor: 4.077
Authors: Jun Ku Chung; Eric Plitman; Shinichiro Nakajima; M Mallar Chakravarty; Fernando Caravaggio; Philip Gerretsen; Yusuke Iwata; Ariel Graff-Guerrero Journal: J Geriatr Psychiatry Neurol Date: 2015-09-23 Impact factor: 2.680
Authors: Kenia Kelly Fiaux do Nascimento; Kelly P Silva; Leandro F Malloy-Diniz; Meryl A Butters; Breno S Diniz Journal: J Psychiatr Res Date: 2015-07-26 Impact factor: 4.791
Authors: C Madeira; M V Lourenco; C Vargas-Lopes; C K Suemoto; C O Brandão; T Reis; R E P Leite; J Laks; W Jacob-Filho; C A Pasqualucci; L T Grinberg; S T Ferreira; R Panizzutti Journal: Transl Psychiatry Date: 2015-05-05 Impact factor: 6.222
Authors: Caroline Madeira; Charles Vargas-Lopes; Carlos Otávio Brandão; Taylor Reis; Jerson Laks; Rogerio Panizzutti; Sergio T Ferreira Journal: Front Psychiatry Date: 2018-11-06 Impact factor: 4.157